Drug intelligence / Profile preview

Yesucom

Development stage: Unknown
Lead developer: Eye and ENT Hospital of Fudan University
Administration: Ophthalmic

Overview

Yesucom is a contact lens moisturizing eye drop (rewetting drop) designed to alleviate ocular surface symptoms and signs, such as dry eye, associated with the use of orthokeratology (OK) lenses. Developed and studied by the Eye & ENT Hospital of Fudan University, it is primarily indicated for managing contact lens-related dry eye in children and adolescents undergoing myopia correction. The formulation acts as a lubricant to enhance comfort and maintain tear film stability during lens wear. In clinical research, Yesucom is evaluated for its efficacy in improving ocular surface health compared to standard 0.1% preservative-free sodium hyaluronate eye drops.

Brand names: Yesucom
Other names: 悦舒康Yesucom eye drops

Beyond the preview

Go deeper on Yesucom.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yesucom.

Explore the full profile